Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

Public Health, Biostatistics, Mathematics +10

Index for rating diagnostic tests

W. J. Youden · Cancer · 1950 · 11.5K citations · Full text

Education, Educational Assessment, Educational Measurement +11

Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

Patrick J. Heagerty, Thomas Lumley, Margaret S. Pepe · Biometrics · 2000 · 2.9K citations

Public Health, Biostatistics, Clinical Epidemiology +16

Association of Multiple Copies of the N-<i>myc</i>Oncogene with Rapid Progression of Neuroblastomas

Robert C. Seeger, Garrett M. Brodeur, Harland N. Sather et al. · New England Journal of Medicine · 1985 · 2K citations

Medicine, Molecular Genetics, Oncology +17

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text

Medicine, Immunology, Oncology +14